Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

64.41
-1.3750-2.09%
Volume:214.84K
Turnover:13.94M
Market Cap:3.14B
PE:-14.90
High:66.10
Open:64.50
Low:64.13
Close:65.78
52wk High:151.02
52wk Low:45.03
Shares:48.77M
Float Shares:29.72M
Volume Ratio:0.63
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3223
EPS(LYR):-3.7900
ROE:-1433.70%
ROA:-25.78%
PB:-245.74
PE(LYR):-16.99

Loading ...

Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says

MT Newswires Live
·
Jul 28

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Reuters
·
Jul 27

Celcuity Inc : Leerink Partners Raises Target Price to $148 from $147

THOMSON REUTERS
·
Jul 27

3 Stocks With Healthy Growth Potential Investors Should Watch

Simply Wall St.
·
Jul 19

Celcuity (CELC) Receives a Buy from Leerink Partners

TIPRANKS
·
Jul 17

3 High Growth Commodity Stocks With Healthy Balance Sheets

Simply Wall St.
·
Jul 17

Baker Bros. Advisors Reports Celcuity Share Disposal Worth $317.5 Million

Reuters
·
Jul 17

Celcuity Shares Fall as Launch Delay Eclipses US Approval for Breast Cancer Drug

Reuters
·
Jul 15

Analysts’ Top Healthcare Picks: Denali Therapeutics (DNLI), Celcuity (CELC)

TIPRANKS
·
Jul 15

Celcuity falls -12.6%

TIPRANKS
·
Jul 15

Movement Alert|Celcuity Inc Falls 22.15% in Regular Trading, FDA Approval of Core Drug Triggers Classic Sell-the-News Selloff

Market Focus
·
Jul 15

Celcuity Shares Fall 22% as Delayed Launch of New Breast Cancer Drug Overshadows First U.S. Approval

THOMSON REUTERS
·
Jul 15

Movement Alert|Celcuity Inc Falls 5.59% in Pre-Market Trading, FDA Approves Core Drug Triggering Sell-the-News Reaction

Market Focus
·
Jul 15

Celcuity is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 15

Celcuity, Inc. : H.c. Wainwright Raises Target Price to $155 from $145

THOMSON REUTERS
·
Jul 15

Celcuity price target raised to $177 from $160 at Citizens

TIPRANKS
·
Jul 15

U.S. Research Roundup-equinix, Goldman Sachs, Jpmorgan

Reuters
·
Jul 15

Movement Alert|Celcuity Inc Declines 5.45% Overnight, Classic Sell-the-News Pattern Following FDA Approval of Core Drug REVTORPYK

Market Focus
·
Jul 15

Stocks to Watch: Pentair, Aehr Test Systems, Celcuity, Schmid Group

Dow Jones
·
Jul 15

Celcuity announces FDA approval of Revtorpyk

TIPRANKS
·
Jul 15